The present disclosure provides for methods of diagnosing and treating bacterial infections. Human Intelectin 1 (hIntL-1) has been shown to bind selectively to glycan components on bacteria including Streptococcus pneumonia, Proteus mirabilis, Proteus vulgaris, Klebsiella pneumonia and Yersinia pestis. This interaction can be targeted to identify, purify and therapeutically target such organisms.
本公开提供了诊断和治疗细菌感染的方法。人类因特蛋白 1(hIntL-1)已被证明可选择性地与细菌(包括肺炎链球菌、奇异变形杆菌、普通变形杆菌、肺炎克雷伯氏菌和鼠疫耶尔森菌)上的聚糖成分结合。这种相互作用可用于识别、纯化和治疗这类
生物。